1904
P. GUGLIELMI ET AL.
21. Berrino E, Supuran CT. Novel approaches for designing
drugs that interfere with pH regulation. Expert Opin Drug
Discov 2019;14:231–48.
References
1. Supuran CT. Exploring the multiple binding modes of inhibi-
tors to carbonic anhydrases for novel drug discovery. Expert
Opin Drug Discov 2020;15:671–86.
2. Supuran CT. Structure and function of carbonic anhydrases.
Biochem J 2016;473:2023–32.
3. Supuran CT. Carbonic anhydrases: novel therapeutic applica-
tions for inhibitors and activators. Nat Rev Drug Discov
2008;7:168–81.
4. Supuran CT. Carbonic anhydrases an overview. Curr Pharm
Des 2008;14:603–14.
5. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors
and their therapeutic potential. Expert Opin Ther Pat 2000;
10:575–600.
6. Supuran CT, Scozzafava A. Carbonic anhydrases as targets
for medicinal chemistry. Bioorganic Med Chem 2007;15:
4336–50.
7. Nocentini A, Supuran CT. Chapter 1 – carbonic anhydrases: an
overview. In: Supuran C.T., Nocentini A.B.T.-C.A. eds. Carbonic
anhydrases. Washington, DC: Academic Press; 2019:3–16.
8. Nocentini A, Donald WA, Supuran CT, Chapter 8 – human
carbonic anhydrases: tissue distribution, physiological role,
and druggability, In: Supuran C.T., Nocentini A.B.T.-C.A. eds.,
Carbonic anhydrases. Washington, DC: Academic Press;
2019: 151–185.
22. Supuran CT. Structure-based drug discovery of carbonic
anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:
759–72.
€
€
23. Guzel-Akdemir O, Akdemir A, Karalı N, Supuran CT.
Discovery of novel isatin-based sulfonamides with potent
and selective inhibition of the tumor-associated carbonic
anhydrase isoforms IX and XII. Org Biomol Chem 2015;13:
6493–9.
24. Di Fiore A, Monti SM, Hilvo M, et al. Crystal structure of
human carbonic anhydrase XIII and its complex with the
inhibitor acetazolamide. Proteins Struct Funct Bioinforma
2009;74:164–75.
25. Angeli A, Pinteala M, Maier SS, et al. Evaluation of thio-and
seleno-acetamides bearing benzenesulfonamide as inhibitor
of carbonic anhydrases from different pathogenic bacteria.
Int J Mol Sci 2020;21:1–8.
26. Angeli A, Peat TS, Selleri S, et al. X-ray crystallography of
Epacadostat in adduct with Carbonic Anhydrase IX. Bioorg
Chem 2020;97:103669.
27. Carradori S, Guglielmi P, Chapter 12, Mechanisms of action
of carbonic anhydrase inhibitors: compounds that bind “out
of the binding site” and compounds with an unknown
mechanism of action. In: Supuran C.T., Nocentini A.B.T.-C.A.
eds., Carbonic Anhydrases. Washington, DC: Academic Press;
2019: 257–268.
9. Provensi G, Carta F, Nocentini A, et al. A new kid on the
block? Carbonic anhydrases as possible new targets in
Alzheimer’s disease. Int J Mol Sci 2019;20:4724.
10. Gul HI, Yamali C, Sakagami H, et al. New anticancer drug
candidates sulfonamides as selective hCA IX or hCA XII
inhibitors. Bioorg Chem 2018;77:411–9.
11. Supuran CT. Carbonic anhydrase activators. Future Med
Chem 2018;10:561–73.
28. Supuran CT. How many carbonic anhydrase inhibition mech-
anisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
29. Scozzafava A, Carta F, Supuran CT. Secondary and tertiary
sulfonamides: a patent review (2008–2012). Expert Opin
Ther Pat 2013;23:203–13.
12. Solesio ME, Peixoto PM, Debure L, et al. Carbonic anhydrase
inhibition selectively prevents amyloid b neurovascular mito-
chondrial toxicity. Aging Cell 2018;17:e12787.
13. Swietach P, Wigfield S, Cobden P, et al. Tumor-associated
carbonic anhydrase 9 spatially coordinates intracellular pH
in three-dimensional multicellular growths. J Biol Chem
2008;283:20473–83.
14. De Simone G, Supuran CT. Carbonic anhydrase IX: biochem-
ical and crystallographic characterization of a novel antitu-
mor target. Biochim Biophys Acta 2010;1804:404–9.
15. Ameis HM, Drenckhan A, Freytag M, et al. Carbonic anhy-
drase IX correlates with survival and is a potential thera-
peutic target for neuroblastoma. J Enzyme Inhib Med Chem
2015;00:1–6.
16. Pastorekova S, Ratcliffe PJ, Pastorek J. Molecular mechanisms
of carbonic anhydrase IX-mediated pH regulation under
hypoxia. BJU Int 2008;101:8–15.
30. Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding
modes of inhibitors to carbonic anhydrases: how to design
specific drugs targeting 15 different isoforms? Chem Rev
2012;112:4421–68.
€
31. Kohler K, Hillebrecht A, Schulze Wischeler J, et al. Saccharin
inhibits carbonic anhydrases: possible explanation for its
unpleasant metallic aftertaste. Angew Chem Int Ed Engl
2007;46:7697–9.
32. Coviello V, Marchi B, Sartini S, et al. 1,2-benzisothiazole
derivatives bearing 4-, 5-, or 6-alkyl/arylcarboxamide moi-
eties inhibit carbonic anhydrase isoform IX (CAIX) and cell
proliferation under hypoxic conditions. J Med Chem 2016;
59:6547–52.
ꢁ
33. Zubriene A, Capkauskaite E, Gylyte J, et al.
Benzenesulfonamides with benzimidazole moieties as inhibi-
tors of carbonic anhydrases I, II, VII, XII and XIII. J Enzyme
Inhib Med Chem 2014;29:124–31.
ꢀ
17. Thiry A, Dogne JM, Masereel B, Supuran CT. Targeting
34. Ivanova J, Leitans J, Tanc M, et al. X-ray crystallography-pro-
moted drug design of carbonic anhydrase inhibitors. Chem
Commun 2015;51:7108–11.
35. Alterio V, Tanc M, Ivanova J, et al. X-ray crystallographic and
kinetic investigations of 6-sulfamoyl-saccharin as a carbonic
anhydrase inhibitor. Org Biomol Chem 2015;13:4064–9.
36. Ivanova J, Carta F, Vullo D, et al. N-Substituted and ring
opened saccharin derivatives selectively inhibit transmem-
brane, tumor-associated carbonic anhydrases IX and XII.
Bioorganic Med Chem 2017;25:3583–9.
tumor-associated carbonic anhydrase IX in cancer therapy.
Trends Pharmacol Sci 2006;27:566–73.
18. Lounnas N, Rosilio C, Nebout M, et al. Pharmacological
inhibition of carbonic anhydrase XII interferes with cell pro-
liferation and induces cell apoptosis in T-cell lymphomas.
Cancer Lett 2013;333:76–88.
19. Supuran CT. Advances in structure-based drug discovery of
carbonic anhydrase inhibitors. Expert Opin Drug Discov
2017;12:61–88.
20. Nocentini A, Supuran CT. Advances in the structural annota-
tion of human carbonic anhydrases and impact on future
drug discovery. Expert Opin Drug Discov 2019;14:1175–97.
37. Carradori S, Secci D, De Monte C, et al. A novel library of
saccharin and acesulfame derivatives as potent and selective